BRPI0507302A - método e composições para o tratamento da lipodistrofia - Google Patents
método e composições para o tratamento da lipodistrofiaInfo
- Publication number
- BRPI0507302A BRPI0507302A BRPI0507302-2A BRPI0507302A BRPI0507302A BR PI0507302 A BRPI0507302 A BR PI0507302A BR PI0507302 A BRPI0507302 A BR PI0507302A BR PI0507302 A BRPI0507302 A BR PI0507302A
- Authority
- BR
- Brazil
- Prior art keywords
- lipodystrophy
- treatment
- compositions
- methods
- hiv patients
- Prior art date
Links
- 206010049287 Lipodystrophy acquired Diseases 0.000 title abstract 5
- 208000006132 lipodystrophy Diseases 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 3
- 102000018997 Growth Hormone Human genes 0.000 abstract 1
- 108010051696 Growth Hormone Proteins 0.000 abstract 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 239000000122 growth hormone Substances 0.000 abstract 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
MéTODOS E COMPOSIçõES PARA O TRATAMENTO DA LIPODISTROFIA. A presente invenção refere-se a métodos e composições para o tratamento de lipodistrofia. Os métodos contemplam o tratamento de lipodistrofia tanto em pacientes com HIV quanto paciente sem HIV. Mais especificamente, os métodos são dirigidos para uma terapia em combinação que emprega hormónio do crescimento e estatinas para efetivar o tratamento de lipodistrofia
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54020404P | 2004-01-29 | 2004-01-29 | |
| US54336604P | 2004-02-10 | 2004-02-10 | |
| PCT/EP2005/000758 WO2005074916A1 (en) | 2004-01-29 | 2005-01-26 | Methods and compositions for the treatment of lipodystrophy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0507302A true BRPI0507302A (pt) | 2007-06-26 |
Family
ID=34841102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0507302-2A BRPI0507302A (pt) | 2004-01-29 | 2005-01-26 | método e composições para o tratamento da lipodistrofia |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1722778A1 (pt) |
| JP (1) | JP2007519669A (pt) |
| KR (1) | KR20060127977A (pt) |
| AU (1) | AU2005210093A1 (pt) |
| BR (1) | BRPI0507302A (pt) |
| CA (1) | CA2552404A1 (pt) |
| EA (1) | EA200601392A1 (pt) |
| IL (1) | IL176762A0 (pt) |
| NO (1) | NO20063279L (pt) |
| WO (1) | WO2005074916A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2903312B1 (fr) | 2006-07-05 | 2008-09-26 | Univ Aix Marseille Ii | Utilisation d'inhibiteurs d'hmg-coa reductase et de farnesyl-pyrophosphate synthase dans la preparation d'un medicament |
| PT2234620E (pt) * | 2008-01-03 | 2016-06-20 | Université D`Aix-Marseille | Terapia tripla usada para o tratamento dum paciente infetado por hiv |
| EP2421548A4 (en) * | 2009-04-20 | 2012-09-26 | Theratechnologies Inc | USE OF (HEXENOYL-TRANS-3) HGRF (L-44) NH2 AND SIMVASTATIN IN COMBINATION THERAPY |
| EP3125921B1 (en) * | 2014-03-11 | 2020-07-08 | Novartis AG | Fgf21 variants for use in treating hiv-haart induced partial lipodystrophy |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9803623D0 (sv) * | 1998-10-22 | 1998-10-22 | Sahltech Ab | New therapeutic application |
-
2005
- 2005-01-26 BR BRPI0507302-2A patent/BRPI0507302A/pt not_active IP Right Cessation
- 2005-01-26 AU AU2005210093A patent/AU2005210093A1/en not_active Abandoned
- 2005-01-26 CA CA002552404A patent/CA2552404A1/en not_active Abandoned
- 2005-01-26 WO PCT/EP2005/000758 patent/WO2005074916A1/en active Application Filing
- 2005-01-26 EP EP05707019A patent/EP1722778A1/en not_active Withdrawn
- 2005-01-26 JP JP2006550092A patent/JP2007519669A/ja active Pending
- 2005-01-26 EA EA200601392A patent/EA200601392A1/ru unknown
- 2005-01-26 KR KR1020067016376A patent/KR20060127977A/ko not_active Application Discontinuation
-
2006
- 2006-07-10 IL IL176762A patent/IL176762A0/en unknown
- 2006-07-14 NO NO20063279A patent/NO20063279L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005210093A1 (en) | 2005-08-18 |
| KR20060127977A (ko) | 2006-12-13 |
| EA200601392A1 (ru) | 2006-12-29 |
| NO20063279L (no) | 2006-09-19 |
| JP2007519669A (ja) | 2007-07-19 |
| WO2005074916A1 (en) | 2005-08-18 |
| IL176762A0 (en) | 2006-10-31 |
| EP1722778A1 (en) | 2006-11-22 |
| CA2552404A1 (en) | 2005-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125077T1 (el) | Αγωγη της ανεπαρκειας και ελλειψης βιταμινης d με 25-υδροξυβιταμινη d2 και 25-υδροξυβιταμινη d3 | |
| NZ593474A (en) | Compositions and methods for treatment of celiac disease | |
| TW200612987A (en) | Combination treatment for non-hematologic malignancies | |
| MX2010006519A (es) | Metodo para tratar una fractura de hueso con anticuerpos anti-esclerostina. | |
| BR0313282A (pt) | Composições de inibidor seletivo de ciclooxigenase-2 e um inibidor de anidrase carbÈnica para o tratamento de neoplasia | |
| DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
| DK1970059T3 (da) | Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser | |
| ECSP074704A (es) | Combinaciones de inhibidor(es) de la absorción de esterol con modificador(es) sanguíneos para tratar cuadros vasculares | |
| EA201000914A1 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
| MX2010002498A (es) | Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol. | |
| MX2009006466A (es) | Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina. | |
| TW200716224A (en) | Method of indentifying therapeutic targets for the treatment of vulvovaginal atrophy | |
| EA201290356A1 (ru) | Композиции для лечения тошноты и рвоты центрального происхождения | |
| SG10201407403UA (en) | Treatments For Gastrointestinal Disorders | |
| DK1505990T3 (da) | Fremgangsmåder til behandling af hepatitis | |
| MX2009005114A (es) | Uso de los profarmacos gabapentina y pregabalina para tratar el tinnitus. | |
| MX349188B (es) | Sns - 595 y metodos para utilizar el mismo. | |
| MX2011012015A (es) | Tratamiento de deterioro cognitivo leve y enfermedad de alzheimer. | |
| WO2008079270A3 (en) | Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis | |
| BR112013022217A8 (pt) | composição farmacêutica, método de tratamento preventivo de uma síndrome hemorrágica em um paciente com hemofilia a ou b e método de tratamento de um acidente hemorrágico em um paciente com hemofilia a ou b | |
| EA201001749A1 (ru) | Способ лечения недифференцированного артрита | |
| NO20072167L (no) | Kombinasjon omfattende ZD6474 og et antiandrogen | |
| DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
| BR112013007423A2 (pt) | terapia combinada no que diz respeito ao tratamento da infecção por hcv | |
| EA201200428A1 (ru) | Композиция и способ для лечения ожирения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: LABORATOIRES SERONO S.A. (CH) Free format text: TRANSFERIDO DE: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A E 6A ANUIDADES |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2099 DE 29/03/2011. |